肝细胞癌
淋巴
网状结缔组织
网状细胞
癌症研究
细胞外基质
免疫系统
病理
医学
干细胞
细胞
癌症
T细胞
肿瘤微环境
生物
间充质干细胞
细胞毒性T细胞
癌细胞
免疫学
癌症干细胞
效应器
树突状细胞
抗原
淋巴结
化学
细胞疗法
作者
Xin Li,Yuchen Yan,Zhaoxia Chen,Jiaqi Qin,Xiaoqiong Zhang,Zhaohan Wei,Jianye Li,Haojie Liu,Shiyu Li,Shiyi Xu,Tuying Yong,Xiangliang Yang,Lu Gan
出处
期刊:
[Elsevier BV]
日期:2025-09-17
卷期号:2 (3): 100195-100195
被引量:1
标识
DOI:10.1016/j.celbio.2025.100195
摘要
Cancer vaccines hold great promise for hepatocellular carcinoma (HCC) treatment. However, changes in lymph nodes, driven by inappropriate activation of fibroblastic reticular cells (FRCs), significantly compromise T cell responses induced by cancer vaccines. Here, we develop a nanovaccine platform based on dendritic cell-derived microparticles overexpressing alpha-fetoprotein (AFP) to deliver calcipotriol (Cal@MPs AFP ). Cal@MPs AFP effectively modulate activated FRCs in lymph nodes, triggering extracellular matrix remodeling and CCR7-CCL19/CCL21 signaling axis. This establishes a self-amplifying loop, enhancing recruitment and accumulation of both naive CD8 + T cells and Cal@MPs AFP within nodal microenvironment. The resultant T cell and Cal@MPs AFP accumulation, coupled with FRC-mediated niche modification, promotes CD8 + T cell activation, proliferation, and differentiation into stem cell-like memory T cells. Consequently, increased presence of memory and effector CD8 + T cells in tumor tissues, synergized with anti-PD-1 antibody, improves therapeutic efficacy and facilitates tumor elimination. These findings underscore a promising strategy to overcome FRC-mediated immune evasion and improve HCC therapeutic efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI